Both in Pharmaceuticals
Braveheart Bio vs Precigen
Over the past year BRVE returned −21.0% and PGEN returned −25.0%; their daily moves had a correlation of 0.12.
BRVE −21.0% PGEN −25.0%Growth of $1, one year, split-adjusted
| Metric | BRVE | PGEN |
|---|---|---|
| Price | $21.04 | $5.14 |
| Market cap | $1.89B | $1.84B |
| Today | −2.19% | −25.94% |
| 1 month | −1.1% | −39.8% |
| 6 months | — | +24.2% |
| Year to date | — | +23.0% |
| 1 year | — | +26.9% |
| Revenue growth (YoY) | — | +6322.7% |
| Gross margin | — | 94.9% |
| Net margin | — | 36.5% |
| P/E (TTM) | — | — |
| Price / sales | — | 21.5× |
| Net cash | — | -$55.7M |
| Dividend yield | — | — |
| Volatility (60d) | — | 86.6% |
| Short % of float | 10.9% | 26.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).